Antioxidant evaluation of heterocyclic compounds by cytokinesis-block micronucleus assay.
This article summarizes the results of using cytokinesis-block micronucleus (CBMN) assay to evaluate the antioxidant potential of heterocyclic compounds. Most studies were carried out with naturally occurring heterocyclic compounds such as plant polyphenols: flavonoids, xanthones, coumarins, and ellagitannins, or plant derived products (juices, extracts, supplements) rich in bioactive heterocyclic compounds. There are also some studies dealing with synthetic heterocyclic antioxidants. CBMN assay is an in vitro study that has been used to evaluate antioxidant and protective effects of heterocyclic compounds on induced chromosome aberration in human lymphocytes.
Institute of Chemistry, Technology and Metallurgy, Njegoseva 12, University of Belgrade, Serbia. dgodjev@chem.bg.ac.rs
Dejan
D
Godevac
Vele
V
Tesević
Vlatka
V
Vajs
Slobodan
S
Milosavljević
Miroslava
M
Stanković
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D048749:Cytokinesis / Q000187:drug effects*; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D006801:Humans; D015162:Micronucleus Tests
D000975:Antioxidants; D006571:Heterocyclic Compounds